A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
Clinical trial NCT06500429 · COMPLETED
Trial details
- NCT number
- NCT06500429
- Sponsor
- Neurogastrx, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2024-09-04
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.